ANGES, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 49 JPY | 0.00% |
|
-2.00% | -31.94% |
| Sales 2022 | 67M 423K 578K | Sales 2023 | 152M 960K 1.31M | Capitalization | 14.23B 89.83M 123M |
|---|---|---|---|---|---|
| Net income 2022 | -14.71B -92.89M -127M | Net income 2023 | -7.44B -46.95M -64.17M | EV / Sales 2022 | 165 x |
| Net cash position 2022 | 9.88B 62.38M 85.26M | Net cash position 2023 | 3.8B 23.98M 32.78M | EV / Sales 2023 | 68.6 x |
| P/E ratio 2022 |
-1.29
x | P/E ratio 2023 |
-1.83
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 96.87% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 week | -2.00% | ||
| Current month | -25.76% | ||
| 1 month | -26.87% | ||
| 3 months | -32.88% | ||
| 6 months | -43.02% | ||
| Current year | -31.94% |
1 week
49.00
51.00
1 month
49.0067.00
Current year
49.0092.00
1 year
49.00143.00
3 years
49.001 060.00
5 years
49.002 492.00
10 years
49.002 492.00
| Managers | Title | Age | Since |
|---|---|---|---|
Tetsuji Yoneo
DFI | Director of Finance/CFO | 54 | 12-09-30 |
Ei Yamada
PSD | President | 73 | 01-04-30 |
Kazuo Suzuki
CTO | Chief Tech/Sci/R&D Officer | 67 | 19-01-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ei Yamada
PSD | President | 73 | 01-04-30 |
Makoto Hara
BRD | Director/Board Member | 73 | 18-03-28 |
Junichi Komamura
BRD | Director/Board Member | 73 | 12-02-29 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 49 | 0.00% | 530,600 |
| 24-04-25 | 49 | 0.00% | 847,400 |
| 24-04-24 | 49 | 0.00% | 515,400 |
| 24-04-23 | 49 | -2.00% | 1,598,600 |
| 24-04-22 | 50 | 0.00% | 1,456,800 |
Delayed Quote Japan Exchange, April 26, 2024 at 02:00 am
More quotes
AnGes, Inc., formerly AnGes MG, Inc., is a Japan-based company mainly engaged in the development of genetic medicines. The Company is involved in the development of hepatocyte growth factor (HGF) genetic medicines, NF-KB decoy oligo and hemagglutinating virus of Japan envelope (HVJ-E) non-viral vector, among others. As of December 31, 2012, the Company had four consolidated subsidiaries. On January 31, 2013, the Company sold a 95.3% stake of a Osaka-based subsidiary to ISHIHARA SANGYO KAISHA LTD.
Calendar
2024-05-09
- Q1 2024 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| -31.94% | 62.66M | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.74B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
- Stock Market
- Equities
- 4563 Stock
